UK markets closed

Kyverna Therapeutics, Inc. (KYTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.50+0.14 (+1.90%)
At close: 04:00PM EDT
7.50 0.00 (0.00%)
After hours: 07:33PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Total revenue
0
0
7,025
5,656
Operating expenses
Research development
63,688
49,923
28,402
25,852
Selling general and administrative
16,631
12,483
8,007
6,150
Total operating expenses
80,319
62,406
36,409
32,002
Operating income or loss
-80,319
-62,406
-29,384
-26,346
Interest expense
187
187
65
3
Total other income/expenses net
-78
-55
-9
-2
Income before tax
-75,916
-60,366
-28,893
-26,350
Income from continuing operations
-75,916
-60,366
-28,893
-26,350
Net income
-75,916
-60,366
-28,893
-26,350
Net income available to common shareholders
-75,916
-60,366
-28,893
-26,350
Basic EPS
-1.18
-1.48
-1.12
-1.02
Diluted EPS
-1.18
-1.48
-1.12
-1.02
Basic average shares
40,823
40,823
25,804
25,804
Diluted average shares
40,823
40,823
25,804
25,804